StockGlow

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK)

Develops cancer-fighting drugs that boost the immune system to attack tumors.

26.00-0.01%Healthcare
Compare 3378.HK with
StockGlow Score
60
Leaning Bullish
BearishBullish
1 year ago+50.9%

The outlook

Hanx Biopharmaceuticals is trading at 26, positioned roughly midway through its 52-week range. Price action shows a mixed trend against moving averages, suggesting neither clear upward nor downward momentum. Analyst coverage appears thin, and the overall lean is moderately bullish based on current data.

What’s behind the score

Price trendMixed vs its moving averages
52-week range64% of the way from its 52-week low to high
Market cap
$3.49B
52-wk high
32.94
52-wk low
13.48
50-day avg
27.77
200-day avg
24.26
Trailing P/E
—

Similar stocks

3382.HKTianjin Port Development Holdings Limited$0.62+1.64%2880.HKLiaoning Port Co., Ltd.$0.71+1.43%3399.HKGuangdong Yueyun Transportation Company Limited$1.37+3.79%3330.HKLingbao Gold Group Company Ltd.$18.96+2.99%3368.HKParkson Retail Group Limited$0.16+2.56%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy